Skip to main content
Clinical Trials/NCT02684305
NCT02684305
Unknown
Phase 3

Stepwise Labor Induction Following Failure of Prostaglandin Vaginal Insert for Labor Induction

Tel-Aviv Sourasky Medical Center0 sites320 target enrollmentApril 2016

Overview

Phase
Phase 3
Intervention
Administration of Propess
Conditions
Induction of Labor
Sponsor
Tel-Aviv Sourasky Medical Center
Enrollment
320
Primary Endpoint
Time from second agent induction to delivery
Last Updated
10 years ago

Overview

Brief Summary

Induction of labor is one of the most common obstetrical medical procedures performed today. Iatrogenic stimulation of uterine contractions prior to the onset of spontaneous labor is undertaken for various maternal and fetal indications and spans 20% of deliveries today.

  1. During the past years there has been an additional rise due to elective inductions
  2. Induction is undertaken when potential risks of prolonging pregnancy outweigh the risks of induced delivery, particularly those associated with post-term pregnancy, rupture of membranes, oligohydramnios and additional fetal and maternal conditions that pose risks to mother and fetus.

In many circumstances of women with an unfavorable cervix (Bishop score of 7 or less) sequential induction with more than one agent is necessary. To date, no trial has compared the optimal subsequent ripening method after the preliminary use of dinoprostone (prostaglandin E2). In this trial investigators aim to compare the obstetrical outcomes of subsequent induction in women admitted for induction of labor with Bishop score <7 or less 24 hours after the insertion of vaginal prostaglandin insert (Propess). Two methods of routine induction of labor will be compared: An additional Propess induction for another 24 hours vs. intravenous oxytocin infusion combined with intra-cervical balloon insertion.

Detailed Description

Induction of labor is one of the most common obstetrical medical procedures performed today. Iatrogenic stimulation of uterine contractions prior to the onset of spontaneous labor is undertaken for various maternal and fetal indications and spans 20% of deliveries today 1. During the past years there has been an additional rise due to elective inductions 2. Induction is undertaken when potential risks of prolonging pregnancy outweigh the risks of induced delivery, particularly those associated with post-term pregnancy, rupture of membranes, oligohydramnios and additional fetal and maternal conditions that pose risks to mother and fetus. In many circumstances of women with an unfavorable cervix (Bishop score of 7 or less) sequential induction with more than one agent is necessary. To date, no trial has compared the optimal subsequent ripening method after the preliminary use of dinoprostone (prostaglandin E2). In this trial investigators aim to compare the obstetrical outcomes of subsequent induction in women admitted for induction of labor with Bishop score \<7 or less 24 hours after the insertion of vaginal prostaglandin insert (Propess). Two methods of routine induction of labor will be compared: An additional Propess induction for another 24 hours vs. intravenous oxytocin infusion combined with intra-cervical balloon insertion.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
April 2018
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Maternal age of 18 years or greater
  • Singleton gestation
  • Bishop score of 7 or less 24 hours after the insertion of Propess
  • Pregnancies at 36+0/7 weeks of gestation and beyond
  • Normal fetal heart rate tracings and normal sonogram at admission (ie Vertex, appropriate for gestational age, biophysical score of 8/8, normal amniotic fluid index)
  • No contraindication for prolongation of pregnancy (e.g. intrauterine infection, placental abruption, etc.)

Exclusion Criteria

  • Situations preventing continuation of induction process in any arm - patient refusal, maternal of fetal conditions necessitating prompt delivery.
  • Rupture of membranes (ROM) after initial Propess insertion.

Arms & Interventions

Administration of Propess

All women who failed induction of labor using vaginal insert slow release of dinoprostone 10 mg (Propess), defined as bishop score ≤ 7 24 hours after propess insertion will be randomized to one of the following treatment arms: 1.Administration of Propess for additional 24 hours.

Intervention: Administration of Propess

Intravenous oxytocin infusion + balloon

All women who failed induction of labor using vaginal insert slow release of dinoprostone 10 mg (Propess), defined as bishop score ≤ 7 24 hours after propess insertion will be randomized to one of the following treatment arms: 2. Intravenous oxytocin infusion combined with intracervical balloon administration, inflated with 60cc of saline.

Intervention: balloon

Intravenous oxytocin infusion + balloon

All women who failed induction of labor using vaginal insert slow release of dinoprostone 10 mg (Propess), defined as bishop score ≤ 7 24 hours after propess insertion will be randomized to one of the following treatment arms: 2. Intravenous oxytocin infusion combined with intracervical balloon administration, inflated with 60cc of saline.

Intervention: Intravenous oxytocin infusion

Outcomes

Primary Outcomes

Time from second agent induction to delivery

Time Frame: 48 hours

Time from second agent induction to active labor

Secondary Outcomes

  • Rate of failed induction defined as 5 cm dilatation(48 hours)
  • Rate of failed induction defined as regular contractions(48 hours)
  • cesarean sections rate(48 hours)

Similar Trials